1. Home
  2. FONR vs QNTM Comparison

FONR vs QNTM Comparison

Compare FONR & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FONR
  • QNTM
  • Stock Information
  • Founded
  • FONR 1978
  • QNTM 1998
  • Country
  • FONR United States
  • QNTM Canada
  • Employees
  • FONR N/A
  • QNTM N/A
  • Industry
  • FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • QNTM
  • Sector
  • FONR Health Care
  • QNTM
  • Exchange
  • FONR Nasdaq
  • QNTM NYSE
  • Market Cap
  • FONR 77.1M
  • QNTM 69.3M
  • IPO Year
  • FONR 1987
  • QNTM N/A
  • Fundamental
  • Price
  • FONR $15.32
  • QNTM $16.85
  • Analyst Decision
  • FONR
  • QNTM
  • Analyst Count
  • FONR 0
  • QNTM 0
  • Target Price
  • FONR N/A
  • QNTM N/A
  • AVG Volume (30 Days)
  • FONR 20.8K
  • QNTM 414.3K
  • Earning Date
  • FONR 05-15-2025
  • QNTM 08-13-2025
  • Dividend Yield
  • FONR N/A
  • QNTM N/A
  • EPS Growth
  • FONR N/A
  • QNTM N/A
  • EPS
  • FONR 1.28
  • QNTM N/A
  • Revenue
  • FONR $103,018,089.00
  • QNTM N/A
  • Revenue This Year
  • FONR N/A
  • QNTM N/A
  • Revenue Next Year
  • FONR N/A
  • QNTM N/A
  • P/E Ratio
  • FONR $12.21
  • QNTM N/A
  • Revenue Growth
  • FONR 0.29
  • QNTM N/A
  • 52 Week Low
  • FONR $12.00
  • QNTM $2.70
  • 52 Week High
  • FONR $18.68
  • QNTM $38.25
  • Technical
  • Relative Strength Index (RSI)
  • FONR 69.66
  • QNTM 46.35
  • Support Level
  • FONR $14.16
  • QNTM $15.88
  • Resistance Level
  • FONR $15.85
  • QNTM $24.32
  • Average True Range (ATR)
  • FONR 0.51
  • QNTM 3.75
  • MACD
  • FONR 0.09
  • QNTM -1.26
  • Stochastic Oscillator
  • FONR 84.55
  • QNTM 4.34

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

About QNTM QUANTUM BIOPHARMA LTD

Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.

Share on Social Networks: